Thrive Program for Fetal Alcohol Spectrum Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called Thrive, designed to help young adults with fetal alcohol spectrum disorders (FASD) set and achieve personal goals. The program involves the young adult and their support network collaborating to plan for the future. Participants are divided into two groups: one starts the program immediately, and the other begins after eight months. The trial seeks young adults in the U.S. with FASD or confirmed prenatal alcohol exposure who can access the internet and speak English. As an unphased trial, this study offers a unique opportunity to contribute to research that may enhance future support programs for young adults with FASD.
Do I need to stop my current medications for the Thrive Program trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on a program rather than medication, so you likely won't need to change your current meds.
What prior data suggests that the Thrive Program is safe for young adults with FASD?
Research has shown that the Thrive program offers a safe and supportive option for young adults with fetal alcohol spectrum disorders (FASD). This program emphasizes person-centered planning, customizing support based on individual priorities. As Thrive is a program rather than a medication, it lacks typical side effects associated with medical treatments.
Participants in similar programs have generally reported positive experiences, indicating an absence of negative effects. Thrive is non-invasive, aiming to enhance quality of life and personal strengths without medical procedures.
While specific data on negative effects for the Thrive program is not available, its design suggests it is a low-risk choice for participants.12345Why are researchers excited about this trial?
The Thrive Program is unique because it offers a structured and supportive approach designed specifically for individuals with Fetal Alcohol Spectrum Disorders (FASD). Unlike current therapies that often focus on managing symptoms with medications or generalized behavioral interventions, the Thrive Program aims to address the root challenges of FASD through targeted behavioral strategies and skills development. Researchers are excited about this program because it has the potential to improve cognitive and social functioning in a more personalized and effective way than existing treatments.
What evidence suggests that the Thrive Program is effective for young adults with FASD?
Research has shown that the Thrive program, which participants in this trial may receive, might assist young adults with fetal alcohol spectrum disorders (FASD). The program emphasizes what matters most to each individual, helping them set and achieve personal goals with support from trusted people. Although detailed results about Thrive's success are not widely available yet, the program employs proven methods that highlight individual strengths and provide personalized support. Early findings suggest that similar programs have benefited people with various developmental challenges, making Thrive a promising choice for those with FASD.12567
Are You a Good Fit for This Trial?
This trial is for young adults with fetal alcohol spectrum disorders (FASD), including those diagnosed with fetal alcohol syndrome. Participants will be involved in a program focusing on their personal goals and support needs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the Thrive program receive person-centered planning support to meet their goals
Follow-up
Participants are monitored for effectiveness of the Thrive program in meeting their goals and receiving support
What Are the Treatments Tested in This Trial?
Interventions
- Thrive Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator